Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 063081

Expand all

TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (TOBRAMYCIN SULFATE)
EQ 1.2MG BASE/ML
Marketing Status: Discontinued

Active Ingredient: TOBRAMYCIN SULFATE
Proprietary Name: TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1.2MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A063081
Product Number: 003
Approval Date: Jul 31, 1990
Applicant Holder Full Name: HOSPIRA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (TOBRAMYCIN SULFATE)
EQ 1.6MG BASE/ML
Marketing Status: Discontinued

Active Ingredient: TOBRAMYCIN SULFATE
Proprietary Name: TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1.6MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A063081
Product Number: 006
Approval Date: Jun 2, 1993
Applicant Holder Full Name: HOSPIRA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (TOBRAMYCIN SULFATE)
EQ 80MG BASE/100ML
Marketing Status: Discontinued

Active Ingredient: TOBRAMYCIN SULFATE
Proprietary Name: TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 80MG BASE/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A063081
Product Number: 001
Approval Date: Jul 31, 1990
Applicant Holder Full Name: HOSPIRA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information